Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver by Hiroyuki Nakai, Roland W. Herzog, J. Nathan.

Slides:

Advertisements

Similar presentations

Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes.

Advertisements

Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization by Viola Lorenz, David Stegner, Simon Stritt, Timo Vögtle, Friedemann.

Induction of granulocytic differentiation by 2 pathways by Pu Zhang, Erik Nelson, Hanna S. Radomska, Junko Iwasaki-Arai, Koichi Akashi, Alan D. Friedman,

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Molecular Therapy - Methods & Clinical Development

Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?

by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima

A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice by Brian D. Brown, Alessio Cantore, Andrea Annoni, Lucia Sergi Sergi,

Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer by George Buchlis, Gregory M. Podsakoff,

by Anja Ehrhardt, and Mark A. Kay

by Jurgen Seppen, Simon C. Barry, Brandon Harder, and William R. A

by Jian-Min Wang, Hong Zheng, Mila Blaivas, and Kotoku Kurachi

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

PDE5A is expressed by podocytes.

T regulatory cells turn on T regulatory cells

A New Strategy for Treatment of Autoimmune Diseases in Chimeric Resistant MRL/lpr Mice by Kenji Takeuchi, Muneo Inaba, Shigeo Miyashima, Ryokei Ogawa,

Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,

A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia by Anja Ehrhardt, Hui.

Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic.

Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice

by Dongmei Song, Xiaobing Ye, Honglei Xu, and Shu Fang Liu

by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald

Volume 14, Issue 1, Pages (July 2006)

by Rajiv Sharma, Xavier M

Volume 16, Issue 3, Pages (March 2008)

Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of.

Factor IX variants improve gene therapy efficacy for hemophilia B

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

Volume 16, Issue 2, Pages (February 2008)

Volume 4, Issue 6, Pages (December 2001)

Volume 9, Issue 2, Pages (February 2004)

Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors by Amine Meliani, Florence Boisgerault, Zachary.

Molecular Therapy - Methods & Clinical Development

Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes Shunsuke Iizuka, Fuminori Sakurai,

Volume 18, Issue 6, Pages (June 2010)

Volume 2, Issue 3, Pages (September 2000)

Molecular Therapy - Methods & Clinical Development

Volume 10, Issue 1, Pages (July 2004)

Volume 21, Issue 4, Pages (April 2013)

Volume 18, Issue 1, Pages (January 2010)

Volume 18, Issue 1, Pages (January 2010)

J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell

Volume 13, Issue 1, Pages (January 2006)

Volume 16, Issue 6, Pages (June 2008)

Volume 12, Issue 5, Pages (November 2005)

Fig. 3 Hepatic HBV envelope RNA and protein expression levels in HBVRplRag−/− mice 7 days (1 week) and 8 to 24 weeks after adoptive transfer with WT or.

Volume 7, Issue 1, Pages (January 2003)

Volume 18, Issue 11, Pages (November 2010)

Volume 5, Issue 6, Pages (June 2002)

Volume 19, Issue 7, Pages (July 2011)

Volume 19, Issue 6, Pages (June 2011)

Volume 12, Issue 5, Pages (November 2005)

Fig. 7. Scale-up of AAV vector–mediated liver gene transfer of secretable GAA to nonhuman primates. Scale-up of AAV vector–mediated liver gene transfer.

Targeted disruption of the RapGEF2 gene.

FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice by Simone Merlin, Rosella Famà, Ester.

Volume 18, Issue 12, Pages (December 2010)

Volume 18, Issue 6, Pages (June 2010)

Sox4 promotes hepatic TG accumulation in vivo.

Volume 25, Issue 4, Pages (April 2017)

Increased phosphorylation of Akt, Girdin S1416, and NR2B of NMDA receptor in the hippocampus of mouse after fear conditioning. Increased phosphorylation.

Volume 19, Issue 5, Pages (May 2011)

Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.

Expression and function of fragment N in RIP-N mice.

Volume 18, Issue 7, Pages (July 2010)

Volume 7, Issue 1, Pages (January 2003)

Volume 7, Issue 1, Pages (January 2003)

Molecular Therapy - Methods & Clinical Development

Shifts in site of hematopoiesis during mouse and human development.

Gene editing in hemophilia: a “CRISPR” choice?

Presentation transcript:

Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver by Hiroyuki Nakai, Roland W. Herzog, J. Nathan Hagstrom, Johannes Walter, Szu- Hao Kung, Edmund Y. Yang, Shing Jen Tai, Yuichi Iwaki, Gary J. Kurtzman, Krishna J. Fisher, Peter Colosi, Linda B. Couto, and Katherine A. High Blood Volume 91(12): June 15, 1998 ©1998 by American Society of Hematology

Map of the AAV vectors AAV-CMV-F.IX (A) and AAV-EF1α-F.IX (B). Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Immunofluorescence staining of human F.IX in mouse liver. Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Western blot to detect the formation of circulating antibody in the plasma of mice injected with 1 to 2 × 1011 particles of AAV-CMV-F.IX at day 1 of life. Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Analyses of genomic DNA isolated from livers after injection of CD-1 mice with 2 × 1011 particles of AAV-CMV-F.IX at day 1 of life. Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology

Immunofluorescence staining of human F.IX expressed in hepatocytes 22 weeks after injection of AAV-CMV-F.IX (A) or AAV-EF1α-F.IX (B and C) into portal vein of adult C57BL/6 mice. Hiroyuki Nakai et al. Blood 1998;91: ©1998 by American Society of Hematology